Your request to link to rcsb for ALK2

  • 3H9R: crystal structure of the kinase domain of type i activin receptor (acvr1) in complex with fkbp12 and dorsomorphin (10.1074/JBC.M112.365932 )
  • 3MTF: crystal structure of the acvr1 kinase in complex with a 2- aminopyridine inhibitor (10.1371/JOURNAL.PONE.0062721 )
  • 3OOM: crystal structure of the acvr1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor k00507
  • 3Q4U: crystal structure of the acvr1 kinase domain in complex with ldn- 193189 (10.1371/JOURNAL.PONE.0062721 )
  • 4BGG: crystal structure of the acvr1 kinase in complex with ldn-213844 (10.1021/JM501177W )
  • 4C02: crystal structure of human acvr1 (alk2) in complex with fkbp12.6 and dorsomorphin
  • 4DYM: crystal structure of the acvr1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor k00135
  • 5OXG: crystal structure of the acvr1 (alk2) kinase in complex with ldn- 212854 (10.1016/J.BONE.2017.09.004 )
  • 5OY6: crystal structure of the acvr1 (alk2) kinase in complex with cyclical inhibitor od36.
  • 5S75: xchem group deposition -- crystal structure of human acvr1 in complex with fm010913a
  • 5S76: xchem group deposition -- crystal structure of human acvr1 in complex with fm010916a
  • 5S77: xchem group deposition -- crystal structure of human acvr1 in complex with xs035133b
  • 5S78: xchem group deposition -- crystal structure of human acvr1 in complex with fm010934a
  • 5S79: xchem group deposition -- crystal structure of human acvr1 in complex with fm010910a
  • 5S7A: xchem group deposition -- crystal structure of human acvr1 in complex with pk012456b
  • 5S7B: xchem group deposition -- crystal structure of human acvr1 in complex with fm000329d
  • 5S7C: xchem group deposition -- crystal structure of human acvr1 in complex with fm000274c
  • 5S7D: xchem group deposition -- crystal structure of human acvr1 in complex with fm010923a
  • 5S7E: xchem group deposition -- crystal structure of human acvr1 in complex with fm010930a
  • 5S7F: xchem group deposition -- crystal structure of human acvr1 in complex with fm010935a
  • 5S7G: xchem group deposition -- crystal structure of human acvr1 in complex with xs035844b
  • 5S7H: xchem group deposition -- crystal structure of human acvr1 in complex with fm010914a
  • 5S7I: xchem group deposition -- crystal structure of human acvr1 in complex with fm010928a
  • 5S7J: xchem group deposition -- crystal structure of human acvr1 in complex with fm000893d
  • 5S7K: xchem group deposition -- crystal structure of human acvr1 in complex with fm010936a
  • 5S7L: xchem group deposition -- crystal structure of human acvr1 in complex with fm010943a
  • 5S7M: xchem group deposition -- crystal structure of human acvr1 in complex with fm000275d
  • 5S7N: xchem group deposition -- crystal structure of human acvr1 in complex with fm010920a
  • 5S7O: xchem group deposition -- crystal structure of human acvr1 in complex with fm007391c
  • 5S7P: xchem group deposition -- crystal structure of human acvr1 in complex with fm010937a
  • 5S7Q: xchem group deposition -- crystal structure of human acvr1 in complex with fm010944a
  • 5S7R: xchem group deposition -- crystal structure of human acvr1 in complex with fm010918a
  • 5S7S: xchem group deposition -- crystal structure of human acvr1 in complex with fm010921a
  • 5S7T: xchem group deposition -- crystal structure of human acvr1 in complex with fm010926a
  • 5S7U: xchem group deposition -- crystal structure of human acvr1 in complex with fm010938a
  • 5S7V: xchem group deposition -- crystal structure of human acvr1 in complex with fm010942a
  • 5S7W: xchem group deposition -- crystal structure of human acvr1 in complex with hm000007h
  • 5S7X: xchem group deposition -- crystal structure of human acvr1 in complex with fm000376d
  • 5S7Y: xchem group deposition -- crystal structure of human acvr1 in complex with fm010933a
  • 5S7Z: xchem group deposition -- crystal structure of human acvr1 in complex with nu074488b
  • 5S80: xchem group deposition -- crystal structure of human acvr1 in complex with fm010946a
  • 5S81: xchem group deposition -- crystal structure of human acvr1 in complex with fm010947a
  • 5S82: xchem group deposition -- crystal structure of human acvr1 in complex with xs035128c
  • 5S83: xchem group deposition -- crystal structure of human acvr1 in complex with fm010948a
  • 5S84: xchem group deposition -- crystal structure of human acvr1 in complex with fm010949a
  • 5S85: xchem group deposition -- crystal structure of human acvr1 in complex with fm000884c
  • 5S86: xchem group deposition -- crystal structure of human acvr1 in complex with fm010952a
  • 5S87: xchem group deposition -- crystal structure of human acvr1 in complex with fm010953a
  • 5S88: xchem group deposition -- crystal structure of human acvr1 in complex with fm010954a
  • 5S89: xchem group deposition -- crystal structure of human acvr1 in complex with fm010957a
  • 5S8A: xchem group deposition -- crystal structure of human acvr1 in complex with nu074484b
  • 5S8B: xchem group deposition -- crystal structure of human acvr1 in complex with fm010960a
  • 5S9K: xchem group deposition -- crystal structure of human acvr1 in complex with fm010955a
  • 6ACR: crystal structure of human alk2 kinase domain with r206h mutation in complex with rk-59638 (10.1248/CPB.C18-00598 )
  • 6EIX: crystal structure of the kinase domain of the q207e mutant of acvr1 (alk2) in complex with a 2-aminopyridine inhibitor k02288
  • 6GI6: crystal structure of the acvr1 (alk2) kinase in complex with a quinazolinone based alk2 inhibitor with a 5-methyl core. (10.1021/ACS.JMEDCHEM.8B00782 )
  • 6GIN: crystal structure of the acvr1 (alk2) kinase in complex with an quinazolinone based alk2 inhibitor with a 4-morpholinophenyl solvent accessible group. (10.1021/ACS.JMEDCHEM.8B00782 )
  • 6GIP: crystal structure of the acvr1 (alk2) kinase in complex with a quinazolinone based alk2 inhibitor with a 2, 5-dimethyl core. (10.1021/ACS.JMEDCHEM.8B00782 )
  • 6I1S: crystal structure of the acvr1 (alk2) kinase in complex with fkbp12 and the inhibitor e6201 (10.1016/J.CCELL.2020.02.002 )
  • 6JUX: crystal structure of human alk2 kinase domain with r206h mutation in complex with rk-71807 (10.1021/ACSOMEGA.9B04245 )
  • 6SRH: crystal structure of the acvr1 (alk2) kinase in complex with the compound m4k2117
  • 6SZM: crystal structure of the acvr1 (alk2) kinase in complex with the compound m4k2009 (10.1021/ACS.JMEDCHEM.0C01199 )
  • 6T6D: crystal structure of the acvr1 (alk2) kinase in complex with the compound m4k2149 (10.1021/ACS.JMEDCHEM.0C00395 )
  • 6T8N: crystal structure of the acvr1 (alk2) kinase in complex with the compound m4k3007
  • 6TN8: crystal structure of the acvr1 (alk2) kinase in complex with the compound bi-9564
  • 6UNQ: kinase domain of alk2-k493a with amppnp
  • 6UNR: kinase domain of alk2-k492a/k493a with amppnp
  • 6UNS: kinase domain of alk2-k492a/k493a with ldn-193189
  • 6Z36: crystal structure of the acvr1 (alk2) kinase in complex with the compound m4k2118
  • 6ZGC: crystal structure of the acvr1 (alk2) kinase in complex with the compound saracatinib (azd0530)
  • 7A21: crystal structure of the acvr1 (alk2) kinase in complex with the compound m4k2158 28-oct-20 7a21 1 title
  • 7C3G: crystal structure of human alk2 kinase domain with r206h mutation in complex with a bicyclic pyrazole inhibitor rk-73134 (10.1016/J.BMCL.2021.127858 )
  • 7NNS: crystal structure of the acvr1 (alk2) kinase in complex with the compound momelotinib